心臟定位市場規模、佔有率及成長分析（按類型、適應症、最終用戶和地區）－2025 年至 2032 年產業預測

2023 年全球心臟定位市場規模為 19.8 億美元，預計將從 2024 年的 21.6 億美元成長到 2032 年的 42.6 億美元，預測期內（2025-2032 年）的複合年成長率為 8.9%。

根據市場洞察，目前約有 1,400 萬美國患有心律不整，這是一個重大的健康挑戰。為了解決這個普遍存在的問題，心臟定位系統應運而生，成為先進的非侵入式解決方案。這項最尖端科技可以捕捉胸部的電脈衝，並將這些訊號與電腦斷層掃描資料結合，以創建心臟的詳細地圖。這些高解析度地圖對於專家來說至關重要，使他們能夠徹底分析心臟複雜的節律模式。心臟定位可以幫助醫療保健專業人員提高對心律不整的認知，從而做出更準確的診斷和個人化的治療方案，最終改善心血管健康這一重要領域的患者預後。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 監管格局

心臟定位市場規模（按類型和複合年成長率）（2025-2032）

• 市場概覽
• 接觸式心臟定位系統
• 非接觸式心臟定位系統

心臟定位市場規模（按適應症和複合年成長率）（2025-2032）

• 市場概覽
• 心房顫動
• 心房撲動
• 房室結迴旋性心搏過速（AVNRT）
• 其他適應症

心臟定位市場規模（按最終用戶和複合年成長率）(2025-2032)

• 市場概覽
• 醫院和診所
• 診斷中心
• 其他最終用戶

心臟定位市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Biosense Webster, Inc.（USA）
• Abbott Laboratories（USA）
• Boston Scientific Corporation（USA）
• Medtronic plc（Ireland）
• Acutus Medical, Inc.（USA）
• AngioDynamics（USA）
• Koninklijke Philips NV（Netherlands）
• Biosig Technologies, Inc.（USA）
• MicroPort Scientific Corporation（China）
• Lepu Medical Technology（Beijing）Co., Ltd.（China）
• Siemens Healthineers AG（Germany）
• GE Healthcare（USA）
• Johnson & Johnson（USA）
• St. Jude Medical, Inc.（USA）
• CardioInsight Technologies, Inc.（USA）
• EP Solutions SA（Switzerland）
• CathVision ApS（Denmark）
• Acutus Medical, Inc.（USA）
• MedLumics（Spain）

結論和建議

Global Cardiac Mapping Market size was valued at USD 1.98 billion in 2023 and is poised to grow from USD 2.16 billion in 2024 to USD 4.26 billion by 2032, growing at a CAGR of 8.9% during the forecast period (2025-2032).

Market insights indicate that around 14 million Americans are currently affected by heart rhythm disorders, highlighting a significant health challenge. In response to this widespread issue, cardiac mapping systems have emerged as an advanced, non-invasive solution. This cutting-edge technology captures electrical impulses from the chest and integrates these signals with computed tomography (CT) scan data to create detailed cardiac maps. These high-resolution maps are essential for specialists, allowing them to analyze the heart's complex rhythm patterns thoroughly. By utilizing cardiac mapping, healthcare professionals can enhance their understanding of heart rhythm disorders, leading to more precise diagnoses and personalized treatment options, ultimately improving patient outcomes in this critical area of cardiovascular health.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiac Mapping market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiac Mapping Market Segments Analysis

Global Cardiac Mapping Market is segmented by Type, Indication, End User and region. Based on Type, the market is segmented into Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems. Based on Indication, the market is segmented into Atrial Fibrillation, Atrial Flutter, Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications. Based on End User, the market is segmented into Hospitals and Clinics, Diagnostic Centers and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cardiac Mapping Market

The Global Cardiac Mapping market is projected to experience significant revenue growth, driven by two primary factors: the increasing incidence of cardiovascular disorders and ongoing innovations in cardiac mapping technology. The World Health Organization (WHO) identifies cardiovascular diseases (CVDs) as the foremost cause of death worldwide, claiming around 17.9 million lives each year. Alarmingly, over 80% of deaths linked to CVDs result from heart attacks and strokes, with many victims under the age of 70. This growing health crisis, coupled with advancements in diagnostic tools, is expected to propel the demand for sophisticated cardiac mapping systems.

Restraints in the Global Cardiac Mapping Market

The Global Cardiac Mapping market faces a significant constraint due to the rising trend towards intricate treatment protocols in cardiac imaging. As medical practices evolve and the complexity of cardiac conditions increases, healthcare providers are compelled to adapt their methodologies to incorporate advanced imaging techniques and detailed mapping solutions. This shift may result in challenges for the established cardiac mapping technologies, which may struggle to keep pace with the demand for more sophisticated treatment options. Consequently, the need for continual innovation and adaptation in the cardiac mapping sector is critical to address the complexities of modern cardiac care effectively.

Market Trends of the Global Cardiac Mapping Market

The Global Cardiac Mapping market is poised for significant growth during the forecast period, fueled by advancements in diagnostic technologies and a rising demand for precise cardiac testing. Medical device companies are at the forefront, innovating and introducing state-of-the-art mapping solutions that enhance the ability to diagnose and treat cardiac conditions. The need for accurate and comprehensive cardiac assessments is escalating due to the increasing prevalence of cardiovascular diseases and aging populations. Additionally, the integration of artificial intelligence and machine learning in cardiac mapping systems is further accelerating market expansion, positioning the sector for robust development in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape

Global Cardiac Mapping Market Size by Type & CAGR (2025-2032)

• Market Overview
• Contact Cardiac Mapping Systems
• Non-Contact Cardiac Mapping Systems

Global Cardiac Mapping Market Size by Indication & CAGR (2025-2032)

• Market Overview
• Atrial Fibrillation
• Atrial Flutter
• Atrioventricular Nodal Reentrant Tachycardia (AVNRT)
• Other Indications

Global Cardiac Mapping Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals and Clinics
• Diagnostic Centers
• Other End Users

Global Cardiac Mapping Market Size & CAGR (2025-2032)

• North America (Type, Indication, End User)
  • US
  • Canada
• Europe (Type, Indication, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Indication, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Indication, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Indication, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Biosense Webster, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acutus Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biosig Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology (Beijing) Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• St. Jude Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CardioInsight Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EP Solutions SA (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CathVision ApS (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acutus Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MedLumics (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations